Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

ClinicalTrials.gov ID: NCT00666900

Public ClinicalTrials.gov record NCT00666900. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 9:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Ranging Study to Evaluate IDP-107 Versus Placebo in the Treatment of Severe Acne Vulgaris With Nodules

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.

Study identification

NCT ID
NCT00666900
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dow Pharmaceutical Sciences
Industry
Enrollment
366 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Feb 28, 2009
Completion
Aug 31, 2009
Last update posted
Feb 19, 2012

2008 – 2009

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Burke Pharmaceutical Research Hot Springs Arkansas 71913
Dermatology Research of Arkansas, PLLC Little Rock Arkansas 72205
RADY Children's Hospital - San Diego San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Solano Clinical Research Vallejo California 94589
Cherry Creek Research, Inc. Denver Colorado 80209
FXM Research Corp. Miami Florida 33175
Michigan Center for Skin Care Research Clinton Township Michigan 48038
Hamzavi Dermatology Fort Gratiot Michigan 48059
Minnesota Clinical Study Center Fridley Minnesota 55432
Skin Specialist, PC Omaha Nebraska 68144
Academic Dermatology Associates Albuquerque New Mexico 87106
Dermatology Associates of Rochester Rochester New York 14623
DermResearchCenter of New York, Inc. Stony Brook New York 11790
University of North Carolina Hospitals and School of Medicine Chapel Hill North Carolina 27599
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Oregon Dermatology and Research Center Portland Oregon 97210
Arlington Research Center, Inc. Arlington Texas 76011
DermResearch, Inc. Austin Texas 78759
J & S Studies, Inc. Bryan Texas 77802
The Center for Skin Research Houston Texas 77056
South Valley Dermatology West Jordan Utah 84088
Virginia Clinical Research, Inc. Norfolk Virginia 23507
Premier Clinical Research Spokane Washington 99204
Madison Skin & Research, Inc. Madison Wisconsin 53719

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00666900, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2012 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00666900 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →